Literature DB >> 9470165

Vincristine therapy for mast cell tumors in dogs.

D L McCaw1, M A Miller, P J Bergman, S J Withrow, A S Moore, D W Knapp, D Fowler, J C Johnson.   

Abstract

Twenty-seven dogs with naturally occurring mast cell tumors were treated with weekly i.v. injections of vincristine (0.75 mg/m2) for 4 treatments. Two dogs (7%) had a partial response. Nine dogs (32%) had treatment stopped prematurely because of toxicity or a perceived deterioration in their quality of life. We conclude that vincristine is ineffective as a sole treatment for measurable mast cell tumors in dogs and produces an undesirable number of adverse reactions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9470165     DOI: 10.1111/j.1939-1676.1997.tb00484.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  3 in total

1.  Use of a reverse saphenous skin flap for the excision of a grade II mast cell tumor on the hind limb of a dog.

Authors:  Catherine Brière
Journal:  Can Vet J       Date:  2002-08       Impact factor: 1.008

2.  Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.

Authors:  C Robat; C London; L Bunting; L McCartan; N Stingle; K Selting; I Kurzman; D M Vail
Journal:  Vet Comp Oncol       Date:  2011-01-31       Impact factor: 2.613

3.  Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Authors:  A Lejeune; K Skorupski; S Frazier; I Vanhaezebrouck; R B Rebhun; C M Reilly; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-05-31       Impact factor: 2.613

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.